Abstract
Tyrosine kinase inhibitors show great promise as clinical therapies, but small molecule inhibitors that are available in the clinic and under development bind to the adenosine triphosphate binding domain of the kinase, potentially limiting efficacy and selectivity. The development of antisense peptide inhibitors is a relatively unexplored area of research, and here we investigate inhibitory peptides specific for the Janus-associated kinase (JAK) family member, tyrosine kinase 2 (TYK2). We have developed peptides that are 2–3 times more selective for TYK2 than other JAK family members, with a TYK2 IC50 of 1.2 μM. In addition, TYK2 inhibitory peptides show specificity for TYK2-mediated functions over JAK1 functions in cell-based assays. These peptides provide a new tool for the development of specific peptide inhibitors for closely related tyrosine kinases.
Keywords: Antisense peptide, JAK, TYK2, tyrosine kinase.
Protein & Peptide Letters
Title:Design of a Peptide Inhibitor of Tyrosine Kinase 2
Volume: 21 Issue: 5
Author(s): Melissa G. Works, Benben Song, Patrick Kibler, Mary J. Tanga, Amit K. Galande and Annalisa D’Andrea
Affiliation:
Keywords: Antisense peptide, JAK, TYK2, tyrosine kinase.
Abstract: Tyrosine kinase inhibitors show great promise as clinical therapies, but small molecule inhibitors that are available in the clinic and under development bind to the adenosine triphosphate binding domain of the kinase, potentially limiting efficacy and selectivity. The development of antisense peptide inhibitors is a relatively unexplored area of research, and here we investigate inhibitory peptides specific for the Janus-associated kinase (JAK) family member, tyrosine kinase 2 (TYK2). We have developed peptides that are 2–3 times more selective for TYK2 than other JAK family members, with a TYK2 IC50 of 1.2 μM. In addition, TYK2 inhibitory peptides show specificity for TYK2-mediated functions over JAK1 functions in cell-based assays. These peptides provide a new tool for the development of specific peptide inhibitors for closely related tyrosine kinases.
Export Options
About this article
Cite this article as:
Works G. Melissa, Song Benben, Kibler Patrick, Tanga J. Mary, Galande K. Amit and D’Andrea Annalisa, Design of a Peptide Inhibitor of Tyrosine Kinase 2, Protein & Peptide Letters 2014; 21(5) . https://dx.doi.org/10.2174/0929866520666131203101841
DOI https://dx.doi.org/10.2174/0929866520666131203101841 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Ethoxidol as a Broad-spectrum Adaptogen
Current Molecular Pharmacology Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.
Anti-Infective Agents in Medicinal Chemistry Effect of Non-antihypertensive Drugs on Endothelial Function in Hypertensive Subjects Evaluated by Flow-mediated Vasodilation
Current Vascular Pharmacology Endocannabinoid Blockade and the Cardiovascular System
Current Drug Therapy Bidirectional Relations Between Anxiety, Depression, and Cancer: A Review
Current Drug Targets Chronic Active EBV Infection and Hypersensitivity to Mosquito Bites: Pathophysiology and Pharmacology
Current Rheumatology Reviews Patterns of NSAIDs Use in Palestinian Mid-Territories: A Prospective Study of Ambulatory Patients in Outpatient Pharmacies
Current Clinical Pharmacology Oral Administration of Sustained Release Niacin Inhibits Platelet Aggregation
Current Clinical Pharmacology Endometriosis: The Role of Pharmacotherapy
Current Women`s Health Reviews Shaping the Genome with Non-Coding RNAs
Current Genomics Coumarine Analogues with Antimycobacterial and Immunomodulatory Activity
Current Bioactive Compounds Lymphoma and the Control of B Cell Growth and Differentiation
Current Molecular Medicine FTY720: A Most Promising Immunosuppressant Modulating Immune Cell Functions
Mini-Reviews in Medicinal Chemistry Oxidative and Nitrosative Stress and Immune-inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
Current Neuropharmacology Systemic Delivery and Quantification of Unformulated Interfering RNAs In Vivo
Current Topics in Medicinal Chemistry Interleukin-7 Biology in HIV Disease and the Path to Immune Reconstitution
Current HIV Research The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model
CNS & Neurological Disorders - Drug Targets Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents
Current Drug Targets Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Current Pharmaceutical Design Cell Bystander Effect Induced by Radiofrequency Electromagnetic Fields and Magnetic Nanoparticles
Current Nanoscience